Oxford University: Investment Portfolio & Startup News
Oxford University
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
Moa Technology unlocks £22m Series C led by Oxford Science Enterprises and Supernova to help farmers protect their harvests from crop-killing weeds
Moa Technology is an agricultural biotechnology business that discovers herbicides with novel modes of action. Its GALAXY screening platform identifies chemistry that kills weeds through mechanisms existing products do not use, giving crop protection companies and the farmers they supply a way to control weeds that have stopped responding to current treatments.
RQ Bio raises a £86m Series A led by Frazier Life Sciences to develop long-acting antibody protection against seasonal influenza
RQ Bio is a UK-based biotechnology company developing long-acting monoclonal antibodies against seasonal influenza. Its lead programme, RQB01, is designed to deliver potent, broad-strain protection against influenza through a dual mechanism of action, targeting patients whose immune systems cannot rely on vaccination alone.
Scripta Therapeutics raises £9m seed led by Oxford Science Enterprises and Apollo Health Ventures to upend conventional drug discovery
Scripta Therapeutics applies AI and experimental biology to map disease-driving transcription networks, aiming to identify new drug targets for neurodegenerative and complex conditions.
Wild Bio secures £45m Series A led by the Ellison Institute of Technology to boost crop resilience by learning from wild species
Wild Bio applies AI and precision breeding to crop genetics, using insights from wild plant species to develop climate-resilient, higher-yield crop varieties for commercial agriculture.
Ultromics raises £40m Series C led by L&G, Allegis Capital and Lightrock to expand AI heart failure diagnostics in the US
Ultromics develops AI software that analyses echocardiograms to help clinicians detect hard-to-diagnose heart failure conditions earlier, without requiring new hardware or changes to existing clinical workflows.
More venture news
- 30 Sept 2026
MetaviewMetaview unlocks a £45m Series C led by Insight Partners to automate hiring with sourcing and screening agents
Series CHR - 23 Sept 2026
Basecamp ResearchBasecamp Research unlocks £105m Series C led by S32 to design medicines with frontier AI models
Series CLife Sciences - 10 Aug 2026
Cambridge AerospaceCambridge Aerospace lands £222m Series C led by DFJ Growth for low-cost drone interceptor missiles
Series CDefence
